AU2001275036A1 - Protected forms of a combination of pharmacologically active agents and uses therefor - Google Patents
Protected forms of a combination of pharmacologically active agents and uses thereforInfo
- Publication number
- AU2001275036A1 AU2001275036A1 AU2001275036A AU7503601A AU2001275036A1 AU 2001275036 A1 AU2001275036 A1 AU 2001275036A1 AU 2001275036 A AU2001275036 A AU 2001275036A AU 7503601 A AU7503601 A AU 7503601A AU 2001275036 A1 AU2001275036 A1 AU 2001275036A1
- Authority
- AU
- Australia
- Prior art keywords
- combination
- active agents
- pharmacologically active
- protected forms
- uses therefor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/55—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug, i.e. a dimer, oligomer or polymer of pharmacologically or therapeutically active compounds
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/586,344 US6306842B1 (en) | 2000-06-02 | 2000-06-02 | Protected forms of a combination of pharmacologically active agents and uses therefor |
| US09586344 | 2000-06-02 | ||
| US58899300A | 2000-06-06 | 2000-06-06 | |
| US09588993 | 2000-06-06 | ||
| PCT/US2001/017480 WO2001093680A1 (en) | 2000-06-02 | 2001-05-30 | Protected forms of a combination of pharmacologically active agents and uses therefor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001275036A1 true AU2001275036A1 (en) | 2001-12-17 |
Family
ID=27079678
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001275036A Abandoned AU2001275036A1 (en) | 2000-06-02 | 2001-05-30 | Protected forms of a combination of pharmacologically active agents and uses therefor |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2001275036A1 (en) |
| WO (1) | WO2001093680A1 (en) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7220749B2 (en) | 2002-06-11 | 2007-05-22 | Nitromed, Inc. | Nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| US7163958B2 (en) | 2002-07-03 | 2007-01-16 | Nitromed Inc. | Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use |
| JP2005538110A (en) | 2002-07-29 | 2005-12-15 | ニトロメッド インコーポレーティッド | Cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| US7632866B2 (en) | 2002-10-21 | 2009-12-15 | Ramot At Tel Aviv University | Derivatives of N-phenylanthranilic acid and 2-benzimidazolone as potassium channel and/or neuron activity modulators |
| US7736624B2 (en) | 2006-06-19 | 2010-06-15 | Univ Vanderbilt | Methods and compositions for diagnostic and therapeutic targeting of COX-2 |
| CN101868443A (en) | 2007-09-20 | 2010-10-20 | 特拉维夫大学拉莫特有限公司 | N-phenyl anthranilic acid derivatives and uses thereof |
| WO2009037705A2 (en) * | 2007-09-20 | 2009-03-26 | Ramot At Tel Aviv University Ltd. | Esters of n-phenylanthranilic acid for use in the treatment of cancer and inflammation |
| CN101954084B (en) * | 2010-09-06 | 2015-06-17 | 北京大北农动物保健科技有限责任公司 | Medicinal composition for treating mixed infection in livestock and poultry and preparation method thereof |
| EP2768499A4 (en) | 2011-10-17 | 2015-08-26 | Univ Vanderbilt | Indomethacin analogs for the treatment of castrate-resistant prostate cancer |
| US10053478B2 (en) * | 2015-01-09 | 2018-08-21 | Reiley Pharmaceuticals, Inc. | COX-2-targeting, platinum-containing conjugates and their use in the treatment of tumors and cancers |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9403857D0 (en) * | 1994-03-01 | 1994-04-20 | Scotia Holdings Plc | Fatty acid derivatives |
| US5607966A (en) * | 1994-12-23 | 1997-03-04 | Alcon Laboratories, Inc. | Esters and amides of non-steroidal anti-inflammatory carboxylic acids which may be used as anti-oxidants, 5-lipoxygenase inhibitors and non-steroidal anti-inflammatory prodrugs |
| US6025353A (en) * | 1997-11-19 | 2000-02-15 | G.D. Searle & Co. | Method of using cyclooxygenase-2 inhibitors as anti-angiogenic agents |
-
2001
- 2001-05-30 AU AU2001275036A patent/AU2001275036A1/en not_active Abandoned
- 2001-05-30 WO PCT/US2001/017480 patent/WO2001093680A1/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001093680A1 (en) | 2001-12-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2001241729A1 (en) | Protected forms of pharmacologically active agents and uses therefor | |
| EP1171117A4 (en) | Long term administration of pharmacologically active agents | |
| AU2001236457A1 (en) | Compounds and compositions for delivering active agents | |
| AU2001263229A1 (en) | Compositions and methods for administration of pharmacologically active compounds | |
| AU2002243277A1 (en) | Methods and compositions for encapsulating active agents | |
| AU2001252135A1 (en) | Therapeutic agents | |
| AU2002235140A1 (en) | Fluidic self-assembly of active antenna | |
| AU2001284985A1 (en) | Compounds and compositions for delivering active agents | |
| AU2001241236A1 (en) | A therapeutic agent of osteoporosis comprising an active ingredient of quercetinderivatives | |
| AU2002223275A1 (en) | A method of expression and agents identified thereby | |
| AU2001288277A1 (en) | Compounds and compositions for delivering active agents | |
| HK1054031A1 (en) | Pharmaceutically active pyrrolidine derivatives | |
| EP1575987A4 (en) | Conjugates of membrane translocating agents and pharmaceutically active agents | |
| AU2002211208A1 (en) | Solution-phase combinatiorial library synthesis and pharmaceutically active compounds produced thereby | |
| AU2001272383A1 (en) | Fungicidal combinations of active agents | |
| AU2001275036A1 (en) | Protected forms of a combination of pharmacologically active agents and uses therefor | |
| EP1154997A4 (en) | Pharmaceutically active compounds and methods of use thereof | |
| AU1969800A (en) | Combination of active agents | |
| AU2001242985A1 (en) | New combination of a betablocker and a cholesterol-lowering agent | |
| IL151589A0 (en) | New combination of a betablocker and a cholestrol-lowering agent | |
| AU4843500A (en) | Destructible surfactants and uses thereof | |
| AU2001229439A1 (en) | Bioconjugates and uses thereof | |
| AU2002316200A1 (en) | Compound and composition for delivering active agents | |
| AU2002338302A1 (en) | Bioregulatory combination of active agents | |
| AU2662799A (en) | Modified pharmacologically active agents and improved therapeutic methods employing same |